Hodgkin's disease: combination chemotherapy in resistant Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D001761:Bleomycin / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use
D001761:Bleomycin; D003606:Dacarbazine; D004317:Doxorubicin; D011241:Prednisone